Skip to main content
Log in

Akute Visusminderung während der Therapie einer chronischen Hepatitis C

Acute loss of vision during therapy of chronic hepatitis C

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Ein Patient mit chronischer Hepatitis C unter der kombinierten Therapie mit pegyliertem Interferon-α-2a (Peg-IFN-α-2a) und Ribavirin entwickelte eine plötzliche ausgeprägte Visusminderung. Es zeigte sich ein Zentralvenenverschluss mit Makulaödem, der mit intravitrealem Bevacizumab behandelt wurde. Retinale Verschlüsse sind als Komplikation der Therapie mit Peg-IFN-α-2a und Ribavirin bekannt. Eine interdisziplinäre Betreuung sowie eine frühe anti-VEGF-Applikation können bei der Therapie dieser Komplikation einer chronischen Hepatitis C von Nutzen sein.

Abstract

A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-α-2a (PEG-IFN-α-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-α-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Gregori NZ, Gaitan J, Rosenfeld PJ et al (2008) Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina 28:1325–1337

    Article  PubMed  Google Scholar 

  2. Kim ET, Kim LH, Lee JI et al (2009) Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol 53:598–602

    Article  PubMed  CAS  Google Scholar 

  3. Marcellin P (2009) Hepatitis B and hepatitis C in. Liver Int 29(Suppl 1):1–8

    Article  PubMed  Google Scholar 

  4. Nadir A, Amin A, Chalisa N et al (2000) Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature. J Viral Hepat 7:466–470

    Article  PubMed  CAS  Google Scholar 

  5. Priglinger SG, Wolf AH, Kreutzer TC et al (2007) Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina 27:1004–1012

    Article  PubMed  Google Scholar 

  6. Rubio JE Jr, Charles S (2003) Interferon-associated combined branch retinal artery and central retinal vein obstruction. Retina 23:546–548

    Article  PubMed  Google Scholar 

  7. Sene D, Touitou V, Bodaghi B et al (2007) Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 13:3137–3140

    PubMed  CAS  Google Scholar 

  8. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558–567

    Article  PubMed  Google Scholar 

  9. Zandieh I, Adenwalla M, Cheong-Lee C et al (2006) Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol 12:4908–4910

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J.P. Salgado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salgado, J., Khoramnia, R., Maier, M. et al. Akute Visusminderung während der Therapie einer chronischen Hepatitis C. Ophthalmologe 108, 561–564 (2011). https://doi.org/10.1007/s00347-010-2327-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-010-2327-0

Schlüsselwörter

Keywords

Navigation